Abstract
Hemophagocytic lymphohistiocytosis (HLH), a disorder of the mononuclear phagocyte system, can be classified into two distinct forms: primary HLH (FHL) and secondary HLH. To clarify the epidemiology and clinical outcome for each HLH subtype, we conducted a nationwide survey of HLH in Japan. Since 799 patients were diagnosed in 292 institutions of Japan between 2001 and 2005, the annual incidence of HLH was estimated as 1 in 800,000 per year. Among them, 567 cases were actually analyzed in this study. The most frequent subtype was Epstein-Barr virus (EBV)-associated HLH, followed by other infection- or lymphoma-associated HLH. Age distribution showed a peak of autoimmune disease- and infection-associated HLH in children, while FHL and lymphoma-associated HLH occurred almost exclusively in infants and the elderly, respectively. The 5-year overall survival rate exceeded 80% for patients with EBV- or other infection-associated HLH, was intermediate for those with FHL or B-cell lymphoma-associated HLH, and poor for those with T/NK cell lymphoma-associated HLH (<15%). Although this nationwide survey establishes the heterogeneous characteristics of HLH, the results should be useful in planning prospective studies to identify the most effective therapy for each HLH subtype.
Similar content being viewed by others
References
Henter J, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis.Sem Oncol. 1991;18:29–33.
Janka GE. Familial erythrophagocytic lymphohistiocytosis.Eur J Pediatr. 1983;140:221–230.
Loy TS, Diaz-Arias AA, Perry MC. Familial erythrophagocytic lymphohistiocytosis.Sem Oncol. 1991;18:34–39.
Caballes RL, Caballes-Ponce MG, Kim DU. Familial hemophagocytic lymphohistiocytosis (FHLH).Pathology. 1997;29:92–95.
Filipovich AH. Hemophagocytic lymphohistiocytosis: a lethal disorder of immune regulation.J Pediatr. 1997;130:337–338.
Janka G, Imashuku S, Elinder G, Schneider M, Henter J-I. Infection-and malignancy-associated hemophagocytoic syndromes. Secondary hemophagocytic lymphohistiocytosis.Hematol/Oncol Clin North Am. 1998;12:435–444.
Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society.Med Pediatr Oncol. 1997;28:342–347.
Henter J-I, Samuelsson-Horne AC, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.Blood. 2002;100:2367–2373.
Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohiosiocytosis with immunochemotherapy.Blood. 1999;93:1869–1874.
Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.Crit Rev Oncol Hematol. 2002;44:259–272.
Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment.IntJ Hematol. 1997;66:135–151.
Tsuda H. Hemophagocytic syndrome (HPS) in children and adults.Int J Hematol. 1997;65:215–226.
Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.World Health Organization Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissue. Lyon, France: IARC Press, 2001.
Kawa K. Hemophagocytic syndrome. Treatment strategies according to classification and scoring system. Education Program Book, Annual Meeting of JSH/JSCH 2005;72–75.
Ishii E, Ohga S, Tanimura M, et al. Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan.Med Pediatr Oncol. 1998;30:276–283.
Imashuku S, Ikushima S, Hibi S, et al. Langerhans cell histiocytosis and hemophagocytic syndrome in Japan: epidemiological studies.Int J Pediatr Hematol/Oncol. 1994;1:241–246.
Su IJ, Wang CH, Cheng AL, et al. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management.Leuk Lymphoma. 1995;19:401–406.
Gurgey A, Secmeer G, Tavil B, et al. Secondary hemophagocytic lymphohistiocytosis in Turkish children.Pediatr Infect Dis J. 2005;24:1116–1117.
Arico M, Danesino C, Pende D, Moretta, L. Pathogenesis of hemophagocytic lymphohistiocytosis.Br J Haematol. 1991;114:761–769.
Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.Blood. 2004; 104:735–743.
Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis.Am Soc Hematol Educ Program. 2005;82–88 [in press].
Ishii E, Ueda I, Shirakawa R, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions.Blood. 2005;105:3442–3448.
Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis.Science. 1999;286:1957–1959.
Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3).Cell. 2003;115:461–473.
zur Stadt U, Schmit S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11.Hum Mol Genet. 2005;14:827–834.
Zaitsu M, Yamamoto K, Ishii E, et al. High frequency of QPY allele and linkage disequilibrium of granzyme B in Epstein-Barr virus associated hemophagocytic lymphohistiocytosis.Tissue Anti. 2005;64:611–615.
Barre V, Marret S, Mendel I, et al. Enterovirus-associated haemophagocytic syndrome in a neonate.Acta Paediatr. 1998;87:469–471.
Jacobs RF. Neonatal herpes simplex virus infections.Sem Perinatol. 1998;22:64–71.
Ishihara S, Okada S, Wakiguchi H, et al. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites.Am J Hematol. 1997;54:276–281.
Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis.Int J Hematol. 2000;72:1–11.
Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.Crit Rev Oncol/ Hematol. 2002;44:251–257.
Takahashi N, Miura I, Chubachi A, et al. A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemopahgocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma.Int J Hematol. 2001; 74:303–308.
Ohno T, Ueda Y, Nagai K, et al. The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.Int J Hematol. 2003;77:286–294.
Fujiwara F, Hibi S, Imashuku S. Hypercytokinemia in hemophagocytic syndrome.Am J Pediatr Hematol Oncol. 1993;15:92–98.
Cheng AL, Su IJ, Chen YC, Uen WC, Wang CH. Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma.Cancer. 1993;72:909–916.
Miyahara M, Sano M, Shibata K, et al. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics.Ann Hematol. 2000;79:378–388.
Shimazaki C, Inaba T, Shimura K, et al. B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study.Br J Haematol. 1999;104:672–679.
Murase T, Nakamura S, Tashiro K, et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphoma-tosis: a report of five cases and review of the literature.BrJ Haematol. 1997;99:656–664.
Murashige N, Kami M, Kishi Y, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer cell neoplasms.Br J Haematol. 2005;130:561–567.
Sekigawa I, Suzuki J, Nawata M, et al. Hemophagocytosis in autoimmune disease.Clin Exp Rheumatol. 2001;19:333–338.
Kumakura S, Ishimura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome.Mod Rheumatol. 2004;14:205–215.
Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome.Am J Med. 1997;102:113–115.
Papo T, Andre MH, Amoura Z, et al. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus.J Rheumatol. 1999;26:927–930.
Suzuki J, Nawata M, Koike M, et al. Two cases of reactive hemophagocytic syndrome: a patient with adult-onset Still’s disease and a patient with herpes zoster and autoimmune abnormalities.Mod Rheumatol. 2001;11:336–339.
Abe Y, Choi I, Hara K, et al. Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloabelative hematopoietic stem cell transplantation.Bone Marrow Transplant. 2002;29:799–801.
Ishikawa J, Maeda T, Miyazaki T, et al. Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation.Int J Hematol. 2000;72:243–246.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ishii, E., Ohga, S., Imashuku, S. et al. Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan. Int J Hematol 86, 58–65 (2007). https://doi.org/10.1532/IJH97.07012
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.07012